| scholarly article | Q13442814 |
| P6179 | Dimensions Publication ID | 1043354602 |
| P356 | DOI | 10.1007/S11912-000-0104-Y |
| P698 | PubMed publication ID | 11122886 |
| P5875 | ResearchGate publication ID | 12205629 |
| P50 | author | C P Reynolds | Q67015887 |
| P2860 | cites work | Prevention of skin cancer in xeroderma pigmentosum with the use of oral isotretinoin | Q28294912 |
| Agents that reverse multidrug resistance, tamoxifen, verapamil, and cyclosporin A, block glycosphingolipid metabolism by inhibiting ceramide glycosylation in human cancer cells | Q28301485 | ||
| Phase I and pharmacokinetic evaluation of all-trans-retinoic acid in pediatric patients with cancer | Q28316780 | ||
| Phase I trial of 13-cis-retinoic acid in children with neuroblastoma following bone marrow transplantation | Q33489400 | ||
| Treatment of high-risk neuroblastoma with intensive chemotherapy, radiotherapy, autologous bone marrow transplantation, and 13-cis-retinoic acid. Children's Cancer Group | Q33876841 | ||
| All-trans retinoic acid in acute promyelocytic leukemias. II. In vitro studies: structure-function relationship. | Q34126018 | ||
| Retinoic acid receptors: transcription factors modulating gene regulation, development, and differentiation | Q35235046 | ||
| Retinoids and their nuclear receptors | Q35280443 | ||
| Differentiation of human neuroblastoma recapitulates neural crest development. Study of morphology, neurotransmitter enzymes, and extracellular matrix proteins | Q35856142 | ||
| Retinoids in cancer therapy | Q36032204 | ||
| Nerve growth factor induces neurite outgrowth in a clone derived from an NGF-insensitive human neuroblastoma cell line. | Q39394742 | ||
| Drug resistance patterns of human neuroblastoma cell lines derived from patients at different phases of therapy. | Q39481908 | ||
| Increase of ceramide and induction of mixed apoptosis/necrosis by N-(4-hydroxyphenyl)- retinamide in neuroblastoma cell lines | Q39511962 | ||
| Synergistic cytotoxicity in solid tumor cell lines between N-(4-hydroxyphenyl)retinamide and modulators of ceramide metabolism | Q39553593 | ||
| A Rationale for the Treatment of Metastatic Neuroblastoma12 | Q40021682 | ||
| Induction of differentiation of human acute myelogenous leukemia cells: therapeutic implications | Q40107588 | ||
| Adverse effects of large doses of vitamin A and retinoids | Q40169085 | ||
| Role of cyclic amp in differentiation of human neuroblastoma cells in culture | Q40341427 | ||
| Involvement of Reactive Oxygen Species in N-(4-Hydroxyphenyl)retinamide-Induced Apoptosis in Cervical Carcinoma Cells | Q41093212 | ||
| N-(4-hydroxyphenyl)retinamide (4-HPR)-mediated biological actions involve retinoid receptor-independent pathways in human breast carcinoma | Q41289818 | ||
| Response of neuroblastoma to retinoic acid in vitro and in vivo | Q41700410 | ||
| 13-cis-retinoic acid (NSC 122758) in the treatment of children with metastatic neuroblastoma unresponsive to conventional chemotherapy: report from the Childrens Cancer Study Group. | Q41950761 | ||
| Regulation of apoptosis induced by the retinoid N-(4-hydroxyphenyl) retinamide and effect of deregulated bcl-2. | Q42280130 | ||
| Hypercalcemia: a dose-limiting toxicity associated with 13-cis-retinoic acid. | Q42286167 | ||
| Effect of the synthetic retinoid fenretinide on dark adaptation and the ocular surface | Q42503866 | ||
| Favorable prognostic significance of high-level retinoic acid receptor beta expression in neuroblastoma mediated by effects on cell cycle regulation. | Q43512650 | ||
| Effects of retinoic acid (RA) on the growth and phenotypic expression of several human neuroblastoma cell lines | Q44036425 | ||
| Decreased expression of N-myc precedes retinoic acid-induced morphological differentiation of human neuroblastoma. | Q44328896 | ||
| Comparison of 13-cis-retinoic acid to trans-retinoic acid using human neuroblastoma cell lines | Q46309123 | ||
| Growth inhibition and induction of apoptosis by fenretinide in small-cell lung cancer cell lines | Q50756405 | ||
| Pharmacokinetic studies of 13-cis-retinoic acid in pediatric patients with neuroblastoma following bone marrow transplantation. | Q50980368 | ||
| Role of antioxidants and intracellular free radicals in retinamide-induced cell death | Q53443698 | ||
| N-(4-hydroxyphenyl)retinamide: interactions with retinoid-binding proteins/receptors | Q53460858 | ||
| The administration of the nerve growth factor to children with widespread neuroblastoma. | Q54750163 | ||
| Improved Inhibitors of Glucosylceramide Synthase | Q57479442 | ||
| N-(4-hydroxyphenyl)retinamide: a Potent Inducer of Apoptosis in Human Neuroblastoma Cells | Q58813531 | ||
| Differentiation Therapy of Acute Promyelocytic Leukemia with Tretinoin (All-trans-Retinoic Acid) | Q67915608 | ||
| Prevention of second primary tumors with isotretinoin in squamous-cell carcinoma of the head and neck | Q68537067 | ||
| Treatment of advanced squamous cell carcinoma of the skin with isotretinoin | Q68772395 | ||
| Isotretinoin and cutaneous helper T-cell lymphoma (mycosis fungoides) | Q70023254 | ||
| Modulation of cell surface antigens accompanies morphological differentiation of human neuroblastoma cell lines | Q70083857 | ||
| 13-cis-retinoic acid plus interferon-alpha 2a in locally advanced squamous cell carcinoma of the cervix | Q70591370 | ||
| Probable in vivo induction of differentiation by retinoic acid of promyelocytes in acute promyelocytic leukaemia | Q70948035 | ||
| Differential effects of N-(4-hydroxyphenyl)retinamide and retinoic acid on neuroblastoma cells: apoptosis versus differentiation | Q72532669 | ||
| Neuroblastoma cell apoptosis induced by the synthetic retinoid N-(4-hydroxyphenyl)retinamide | Q72721420 | ||
| Expression of retinoic acid receptors alpha, beta, and gamma in human neuroblastoma cell lines | Q72835469 | ||
| Phase I trial and pharmacokinetic study of all-trans-retinoic acid administered on an intermittent schedule in combination with interferon-alpha2a in pediatric patients with refractory cancer | Q73863065 | ||
| P433 | issue | 6 | |
| P304 | page(s) | 511-518 | |
| P577 | publication date | 2000-11-01 | |
| P13046 | publication type of scholarly work | review article | Q7318358 |
| P1433 | published in | Current Oncology Reports | Q2264969 |
| P1476 | title | Differentiating agents in pediatric malignancies: retinoids in neuroblastoma | |
| P478 | volume | 2 |
| Q100430297 | 9-cis-UAB30, a novel rexinoid agonist, decreases tumorigenicity and cancer cell stemness of human neuroblastoma patient-derived xenografts |
| Q40720690 | A high-content morphological screen identifies novel microRNAs that regulate neuroblastoma cell differentiation |
| Q33438627 | A rapid, sensitive and selective liquid chromatography/atmospheric pressure chemical ionization tandem mass spectrometry method for determination of fenretinide (4-HPR) in plasma |
| Q24297017 | Activation of the phosphatidylinositol 3-kinase/Akt signaling pathway by retinoic acid is required for neural differentiation of SH-SY5Y human neuroblastoma cells |
| Q39489520 | Ago1 and Ago2 differentially affect cell proliferation, motility and apoptosis when overexpressed in SH-SY5Y neuroblastoma cells |
| Q40083710 | ArrayCGH-based classification of neuroblastoma into genomic subgroups |
| Q80510573 | Biology and therapy of malignant solid tumors in childhood |
| Q38068818 | Children's Oncology Group's 2013 blueprint for research: neuroblastoma |
| Q39227585 | Dinutuximab for maintenance therapy in pediatric neuroblastoma |
| Q33931217 | Distinct mechanisms of cell cycle arrest control the decision between differentiation and senescence in human neuroblastoma cells. |
| Q58103533 | Efficiency of All-Trans Retinoic Acid on Gastric Cancer: A Narrative Literature Review |
| Q51040466 | Expression of the Novel All-trans Retinoic Acid-related Resistance Gene HA117 in Pediatric Solid Tumors |
| Q35033271 | Focus on embryonal malignancies |
| Q37689018 | From carrot to clinic: an overview of the retinoic acid signaling pathway |
| Q47171263 | Graphene Oxide-Silver Nanoparticles Nanocomposite Stimulates Differentiation in Human Neuroblastoma Cancer Cells (SH-SY5Y). |
| Q40854486 | Inhibition of hypoxia inducible factors combined with all-trans retinoic acid treatment enhances glial transdifferentiation of neuroblastoma cells |
| Q39109172 | Inhibitory effects of p-dodecylaminophenol on the invasiveness of human fibrosarcoma cell line HT1080 |
| Q52978029 | Lysophosphatidylcholine Drives Neuroblast Cell Fate |
| Q34953372 | Metabolic characteristics of 13-cis-retinoic acid (isotretinoin) and anti-tumour activity of the 13-cis-retinoic acid metabolite 4-oxo-13-cis-retinoic acid in neuroblastoma |
| Q54265665 | Neuroblastoma |
| Q34180699 | Neuroblastoma: biological insights into a clinical enigma |
| Q41854221 | Pharmacokinetics of the time-dependent elimination of all-trans-retinoic acid in rats |
| Q28833723 | Phenotypic chemical screening using a zebrafish neural crest EMT reporter identifies retinoic acid as an inhibitor of epithelial morphogenesis |
| Q46156427 | Post-chemotherapy maturation in supratentorial primitive neuroectodermal tumors |
| Q40629920 | Potent Cytotoxic Effects of Novel Retinamide Derivatives in Ovarian Cancer Cells |
| Q46035981 | Premature physeal closure following 13-cis-retinoic acid and prolonged fenretinide administration in neuroblastoma. |
| Q81364833 | Results of a Phase I study utilizing monocyte-derived dendritic cells pulsed with tumor RNA in children with Stage 4 neuroblastoma |
| Q30408649 | Retinoic acid actions through mammalian nuclear receptors |
| Q46699463 | Retinoic acid receptors and tissue-transglutaminase mediate short-term effect of retinoic acid on migration and invasion of neuroblastoma SH-SY5Y cells |
| Q35923727 | Retinoic acid-induced CHD5 upregulation and neuronal differentiation of neuroblastoma. |
| Q45721364 | Retinoid Receptors in Gastric Cancer: Expression and Influence on Prognosis |
| Q34476968 | Retinoid therapy of childhood cancer. |
| Q37809078 | Retinoids, Retinoic Acid Receptors, and Cancer |
| Q93342988 | Skeletal Morbidity in Children and Adolescents during and following Cancer Therapy |
| Q24297577 | Small ubiquitin-related modifier-1 modification regulates all-trans-retinoic acid-induced differentiation via stabilization of retinoic acid receptor α |
| Q44512769 | Specificity of photosensitizer accumulation in undifferentiated versus differentiated colon carcinoma cells |
| Q36301706 | Synthesis of short retinoidal amides related to fenretinide: antioxidant activities and differentiation-inducing ability. |
| Q46815335 | Targeting cyclin D1, a downstream effector of INI1/hSNF5, in rhabdoid tumors |
| Q89842629 | The PLAGL2/MYCN/miR-506-3p interplay regulates neuroblastoma cell fate and associates with neuroblastoma progression |
| Q34570078 | The promise of retinoids to fight against cancer. |
| Q58544569 | Traffic lights for retinoids in oncology: molecular markers of retinoid resistance and sensitivity and their use in the management of cancer differentiation therapy |
| Q38300511 | microRNA-449a functions as a tumor suppressor in neuroblastoma through inducing cell differentiation and cell cycle arrest. |
Search more.